Add to ORKGA novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemi
We describe unusual clinical and cytogenetic findings of a 29-year-old female with a Philadelphia ch...
Natural history of chronic myelomonocytic leukemia: gene sequencing identifies multiple clonal molec...
“Myeloproliferative disorders (MPDs) ” were first defined by William Dameshek in 1951: chronic myelo...
We have identified a novel 7.7 Mb del(8)(q23.2q24.11) in a patient progressing to acute myeloid leuk...
AbstractWe have identified a novel 7.7Mb del(8)(q23.2q24.11) in a patient progressing to acute myelo...
AbstractWe have identified a novel 7.7Mb del(8)(q23.2q24.11) in a patient progressing to acute myelo...
AbstractChronic myeloid neoplasms have susceptibility to transform into acute myeloid leukemia due t...
Translocation t(8;9)(p22;p24) has been reported in diverse he-matologic neoplasms, including acute l...
The JAK2V617F point mutation has been implicated in the pathogenesis of the vast majority of myelopr...
International audienceThe JAK2(V617F) mutation does not elucidate the phenotypic variability observe...
International audienceThe JAK2(V617F) mutation does not elucidate the phenotypic variability observe...
International audienceThe JAK2(V617F) mutation does not elucidate the phenotypic variability observe...
We have identified a novel, recurrent t(8;9)(p21–22;p23–24) in six patients with diverse hematologic...
JAK2 V617F mutation and BCR-ABL translocation have been considered to be mutually exclusive. However...
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukem...
We describe unusual clinical and cytogenetic findings of a 29-year-old female with a Philadelphia ch...
Natural history of chronic myelomonocytic leukemia: gene sequencing identifies multiple clonal molec...
“Myeloproliferative disorders (MPDs) ” were first defined by William Dameshek in 1951: chronic myelo...
We have identified a novel 7.7 Mb del(8)(q23.2q24.11) in a patient progressing to acute myeloid leuk...
AbstractWe have identified a novel 7.7Mb del(8)(q23.2q24.11) in a patient progressing to acute myelo...
AbstractWe have identified a novel 7.7Mb del(8)(q23.2q24.11) in a patient progressing to acute myelo...
AbstractChronic myeloid neoplasms have susceptibility to transform into acute myeloid leukemia due t...
Translocation t(8;9)(p22;p24) has been reported in diverse he-matologic neoplasms, including acute l...
The JAK2V617F point mutation has been implicated in the pathogenesis of the vast majority of myelopr...
International audienceThe JAK2(V617F) mutation does not elucidate the phenotypic variability observe...
International audienceThe JAK2(V617F) mutation does not elucidate the phenotypic variability observe...
International audienceThe JAK2(V617F) mutation does not elucidate the phenotypic variability observe...
We have identified a novel, recurrent t(8;9)(p21–22;p23–24) in six patients with diverse hematologic...
JAK2 V617F mutation and BCR-ABL translocation have been considered to be mutually exclusive. However...
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukem...
We describe unusual clinical and cytogenetic findings of a 29-year-old female with a Philadelphia ch...
Natural history of chronic myelomonocytic leukemia: gene sequencing identifies multiple clonal molec...
“Myeloproliferative disorders (MPDs) ” were first defined by William Dameshek in 1951: chronic myelo...